Milestone Pharmaceuticals (MIST) Interest & Investment Income (2018 - 2021)
Milestone Pharmaceuticals' (MIST) quarterly Interest & Investment Income came in at $34000.0 in Q4 2021, down 64.58% YoY from $96000.0 in Q4 2020, and down 29.17% on a QoQ basis from $48000.0 in Q3 2021.
Milestone Pharmaceuticals (MIST) Interest & Investment Income (2018 - 2021) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 4 years of Interest & Investment Income data on file, last reported at $34000.0 in Q4 2021.
- Quarterly Interest & Investment Income fell 64.58% year-over-year to $34000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $220000.0 (down 69.7% YoY) and the FY2021 annual result came in at $220000.0, down 69.7% from the prior year.
- Interest & Investment Income fell to $34000.0 in Q4 2021, from $48000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $821000.0 in Q3 2019 to a low of $34000.0 in Q4 2021.
- A 4-year average of $265750.0 and a median of $93000.0 in 2018 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2019 — Interest & Investment Income surged 865.88% — and 2020, when it slumped 89.16%.
- Tracing MIST's Interest & Investment Income over 4 years: stood at $446000.0 in 2018, then soared by 35.2% to $603000.0 in 2019, then plunged by 84.08% to $96000.0 in 2020, then tumbled by 64.58% to $34000.0 in 2021.
- The last three Interest & Investment Income figures came in at $34000.0 (Q4 2021), $48000.0 (Q3 2021), and $58000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 58,000.00 |
| Mar 31, 2021 | 80,000.00 |
| Dec 31, 2020 | 96,000.00 |
| Sep 30, 2020 | 89,000.00 |
| Jun 30, 2020 | 126,000.00 |
| Mar 31, 2020 | 415,000.00 |
| Dec 31, 2019 | 603,000.00 |
| Sep 30, 2019 | 821,000.00 |
| Jun 30, 2019 | 672,000.00 |
| Mar 31, 2019 | 500,000.00 |
| Dec 31, 2018 | 446,000.00 |
| Sep 30, 2018 | 85,000.00 |
| Jun 30, 2018 | 89,000.00 |
| Mar 31, 2018 | 90,000.00 |